Close
What would you like to look for?
Site search
Search filters

BioVersys completes its IPO at SIX Swiss Exchange

7 February 2025

BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multidrug-resistant (MDR) bacteria, has completed its Initial Public at the SIX Swiss Exchange.

ATANIS Biotech completes Financing Round

28 January 2025

ATANIS Biotech, a Swiss biotechnology company specializing in advanced allergy diagnostics, has successfully completed an oversubscribed financing round led by Spectrum Moonshot Fund and supported by experienced investors in the allergy field.

Ikerian closes Series B Financing with strategic partnership

15 November 2024

Ikerian, a healthcare software platform company that organizes multimodal data at-scale, closes the first tranche of USD 8m Series B Financing to advance its AI platform alongside.

MegaCAD aquires Bausoft Informatik AG

16 October 2024

MegaCAD GmbH acquires Bausoft Informatik AG, a leading Swiss software manufacturer for building engineering services.

ImmunOs Therapeutics AG closes Series C financing round

11 October 2024

ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class therapeutics for the treatment of cancer and autoimmune diseases based on its unique immune system modulating technology platform, closed a Series C financing round.

Santis Pharma receives investment from Abenex

4 October 2024

The founders of Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements with health benefits, have entered into a partnership with Abenex, a French private equity investor.

HAYA Therapeutics Announces Collaboration with Eli Lilly

5 September 2024

HAYA Therapeutics SA, a Swiss biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics, announced a multi-year agreement with Eli Lilly and Company to apply HAYA’s advanced RNA-guided regulatory genome platform to support preclinical drug discovery efforts in obesity and related metabolic conditions.

Genedata Joins Danaher Corporation

23 August 2024

Genedata AG (“Genedata”), a leading provider of software solutions for biopharmaceutical research and development, has been acquired by Danaher Corporation (NYSE: DHR) (“Danaher”), a leading global innovator in life sciences and diagnostics.

Mininavident AG acquired by global dental leader Straumann Group

16 August 2024

Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, was acquired by the Straumann Group, a global leader in tooth replacement, orthodontic solutions and adjacent dental technologies.

FIT Voltaira Group acquires Auto-Kabel Group

26 July 2024

FIT Voltaira Group, a leading supplier of sensor, connectivity, and electrification solutions, announced the acquisition of the globally operating Auto-Kabel Group, a pioneer in e-mobility.